Trishna Goswami

Company: IN8Bio

Job title: Chief Medical Officer

Seminars:

Clinical Data Update: DeltEx DRI Auto, DeltEx Allo, DeltEx nsCAR-T INB-300 & iPSC Derived Gamma-Delta T Cells 9:45 am

DeltEx DRI Auto, is a genetically modified autologous gamma-delta T cell product candidate for the treatment of newly diagnosed GBM solid tumors DeltEx Allo, is an allogeneic product candidate initially developed for the treatment of patients with acute leukemia DeltEx nsCAR-T INB-300 is our DeltEx DRI non-signaling CAR (nsCAR) platform with several preclinical product candidates,…Read more

day: Conference Day One